In an attempt to improve both the resectability and survival rates for bronchogenic carcinoma, pre-operative supervoltage radiotherapy was introduced in 1961 and continued for a period of three years. Patients with either a histological or cytological diagnosis were given a tumour dose of 4,500 r over six weeks and then a two-month period elapsed before surgery. A follow-up of cases treated during the period revealed a five-year survival rate of 15-7%. This rate is low when compared with the results achieved at this hospital with surgery alone. This finding is attributed to the harmful effects of radiotherapy which have led to a high bronchopleural fistula rate of 15-5%. A single case of myocardial radionecrosis also occurred. No improvement is noted in the resectability rate. An overall assessment is that radiotherapy has provided no benefits but has in fact greatly increased both the morbidity and mortality rates.
Bronchogenic carcinoma remains the commonest neoplasm responsible for hospital admissions in New Zealand males. The number undergoing resection for carcinoma among cases referred to the Green Lane Hospital Chest Clinic remains at about 20-25%. Recent papers have shown that the five-year survival rate after resection of bronchial carcinoma is about 25% (Belcher and Anderson, 1965; Goldman, 1965; Clagett, Allen, Payne, and Woolner, 1964; Bignall, Martin, and Smithers, 1967) and in some series it has been notably higher than this (Flavell, 1962) . In an attempt to increase the resection rate, and following an optimistic report by Bloedorn and Cowley (1960) There is good experimental evidence to suggest that irradiation helps to prevent the growth of disseminated cancer cells (Feder and Blair, 1964; Hoye and Smith, 1961) . It might be expected to cut down the incidence of metastases arising locally or distally as a result of the operation. A high rate of bronchopleural fistulae following post-irradiation surgery had previously been reported by Bromley and Szur (1955) , and this was acknowledged as a possible limiting factor to this combined therapy.
SELECTION
The majority of cases seen at the chest clinic were assessed as being inoperable. Another group of cases originally considered operable developed signs of inoperability in the course of treatment. The factors determining inoperability included the presence of distant metastases, age over 70 years, a poor respiratory reserve, a serious associated illness, a positive scalene node biopsy, a phrenic nerve palsy, brachial plexus lesions or chest wall involvement. The presence of enlarged mediastinal lymph nodes seen on a barium swallow or at exploratory thoracotomy did not contraindicate an attempt at post-irradiation resection.
If these inoperable patients are excluded the remaining patients fall into three groups: GROUP A These patients received supervoltage radiotherapy followed by surgery two months later. GROUP B These patients had no pre-operative histological diagnosis. If at exploratory thoracotomy they were regarded as particularly suitable for a primary resection this was performed. GROUP C At exploratory thoracotomy these patients were regarded as inoperable.
METHOD
An estimated tumour dose of 4,500 r was delivered by daily fractions over four weeks, using supervoltage therapy (4 MeV). The fields included the primary tumour and the important lymph drainage areas. An interval of two months elapsed until resection. Whenever possible a lobectomy was performed in preference to pneumonectomy. The ipsilateral media-457 A total of nine (15 5%) group A patients developed bronchopleural fistulae. All of these patients eventually died, usually after a very unpleasant illness. Usually the fistulae occurred before the fourth week, but on occasions the onset was delayed several months. Four of these nine patients had proved concomitant metastatic disease. No bronchopleural fistulae occurred in the non-irradiated surgical group.
Radionecrosis of the myocardium, leading to fatal operative haemorrhage, occurred once; this case has been reported elsewhere (Windsor, 1963) . Sudden deaths of presumed cardiac origin occurred in six other patients, but there is no evidence to establish any relationship with the supervoltage therapy.
The supervoltage therapy made tissues thicker than normal during the hilar dissection but this did not make the operation more difficult. A resectability rate of 79% was achieved among the cases coming to surgery.
The 58 post-irradiation surgical cases (Table  II) (Reid and Carr, 1961) . Two tumours were classified by cytology alone. Histological examination revealed that in 13 of the 58 irradiated surgical specimens there were no viable tumour cells visible in either the lung or lymph nodes. However, only three of these 13 cases that had been 'sterilized' by radiotherapy survived three years.
In order to obtain a comparison with a group of patients who received no pre-operative radiotherapy a study was made of patients operated upon for lung carcinoma over the three-year period, 1957-59. During this period 81 patients had pulmonary resections (Table I ) and a resectability rate of 75% was achieved. There were five post-operative deaths, which included the only case of bronchopleural fistula in the series, an overall incidence therefore of 1 6%.
Two of the patients remain untraced and are classified as late deaths. There have been 21 (26%) three-year survivals and 19 (23 5%) fiveyear survivals. The ratio of pneumonectomies to lobectomies performed in this earlier group was higher than in the post-irradiation group.
The histology of the resected specimens (Table   1I ) was similar except for a slightly higher incidence of adenocarcinoma.
DISCUSSION
Delaying surgery for two months after supervoltage radiotherapy, as recommended by Bloedorn and Cowley (1960) , has in this series of 58 cases (group A) produced a three-and five-year survival rate of 12-1%. The overall five-year survival rate of group A and group B cases is 15-7%. Though the series are not exactly comparable, Linberg, Cowley, Bloedorn, and Wizenberg (1965) , in a follow-up of 82 post-irradiation resections, reported a 17% three-year survival rate. These figures are lower than the three-and even fiveyear survival rates for surgery alone achieved at this hospital, and also reported in other series. No important difference in the resectability rate has been achieved with radiotherapy. These results and the later experience of Linberg et al. (1965) have shown that better results are not achieved by this combined therapy. The results are disappointing and are similar to those originally reported by Bromley and Szur (1955) . The number of resections performed during the period of pre-operative irradiation was less than when this therapy was not used. This discrepancy can be explained by a number of cases that developed metastases or other inoperable features during the four months that elapsed between the beginning of radiotherapy and the date when surgery was planned.
A bronchopleural fistula rate of 15-5% among the irradiated group is high and compares unfavourably with a 1-5% incidence in a large group of cases reported by Flavell (1962) using surgery alone and the 1 6% incidence obtained in this hospital before the introduction of pre-operative radiotherapy. These results are in accord with the high rate of empyema and bronchopleural fistula of 27% and 25-6% reported respectively by Bromley and Szur (1955) and Linberg et al. (1965) . This high incidence is attributed to impaired tissue healing and lowered tissue resistance resulting from radiotherapy. A single case of radiation damage to the myocardium was encountered, but this would seem an uncommon complication. Paulson (1968) has established that preoperative irradiation is justified for bronchogenic carcinoma of the 'superior pulmonary sulcus' producing Pancoast's syndrome. He has achieved a 35% five-year survival rate in a group which in the past has generally been considered hopeless.
There is little doubt that supervoltage radiotherapy has a profound effect on the primary tumour and the hilar and mediastinal lymph node metastases. Twenty-five per cent of the lung specimens and lymph nodes had been 'sterilized' by radiotherapy, and even higher figures have been reported by Bromley and Szur (1955) and Bloedorn and Cowley (1960) . The three-year survival rate of the 'sterilized' cases has, however, shown no significant improvement. Baker, Cowley, and Linberg (1963) reported on 17 cases of 'locally cured' bronchogenic carcinoma with only one survivor after three and a half years.
The prognosis of patients with small and large cell tumours was worse than that of those with squamous type tumours, but the numbers are too small to draw conclusions. According to Siddons (1962) , the five-year survival rates are not sufficiently different to single out any one histological type for separate consideration in therapy.
CONCLUSIONS
Seventy-one cases of bronchogenic carcinoma treated by surgical excision are discussed, 58 of them having had pre-operative radiotherapy and delayed surgery.
A comparison is made with 81 patients who had surgical excision prior to the introduction of preoperative radiotherapy.
Thirteen cases had been 'sterilized' by supervoltage radiotherapy, but the prognosis remained poor.
A low three-year survival of 15 7% is reported. Post-irradiation complications included one case of myocardial radionecrosis and nine cases (15 5%) of bronchopleural fistula.
The combined treatment of supervoltage therapy plus surgery has produced worse results than might have been expected from surgery alone, and this is believed to be due to the complications of radiotherapy.
